102 related articles for article (PubMed ID: 20185963)
21. Discordant quantitative detection of putative biomarkers in nodal micrometastases of colorectal cancer: biological and clinical implications.
Kong SL; Salto-Tellez M; Leong AP; Chan YH; Koay ES
J Clin Pathol; 2005 Aug; 58(8):839-44. PubMed ID: 16049286
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer.
Funada Y; Noguchi T; Kikuchi R; Takeno S; Uchida Y; Gabbert HE
Oncol Rep; 2003; 10(2):309-13. PubMed ID: 12579264
[TBL] [Abstract][Full Text] [Related]
23. Detection of occult metastases in lymph nodes from patients with colorectal carcinoma by reverse transcriptase-polymerase chain reaction.
Liu Z; Ye X; Bi W; Wang M; Li Y; Chen T
Chin Med J (Engl); 2002 Apr; 115(4):529-31. PubMed ID: 12133290
[TBL] [Abstract][Full Text] [Related]
24. Tissue factor expression and metastatic potential of colorectal cancer.
Shigemori C; Wada H; Matsumoto K; Shiku H; Nakamura S; Suzuki H
Thromb Haemost; 1998 Dec; 80(6):894-8. PubMed ID: 9869156
[TBL] [Abstract][Full Text] [Related]
25. [Expression of cathepsin B and its clinical importance in colorectal cancer].
Yu B; Li SY; An P; Zuo FY; Cai HY
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):507-9. PubMed ID: 16299652
[TBL] [Abstract][Full Text] [Related]
26. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
27. Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer.
Mukai M; Sato S; Nishida T; Komatsu N; Shiba K; Nakasaki H; Makuuchi H
Oncol Rep; 2003; 10(6):1753-8. PubMed ID: 14534691
[TBL] [Abstract][Full Text] [Related]
28. Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers.
Legendre H; Decaestecker C; Nagy N; Hendlisz A; Schüring MP; Salmon I; Gabius HJ; Pector JC; Kiss R
Mod Pathol; 2003 May; 16(5):491-504. PubMed ID: 12748256
[TBL] [Abstract][Full Text] [Related]
29. Blood vessel invasion in metastatic nodes for development of liver metastases in colorectal cancer.
Kotanagi H; Fukuoka T; Shibata Y; Yoshioka T; Aizawa O; Saito Y; Koyama K
Hepatogastroenterology; 1995; 42(6):771-4. PubMed ID: 8847020
[TBL] [Abstract][Full Text] [Related]
30. Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma.
Xie D; Sham JS; Zeng WF; Lin HL; Bi J; Che LH; Hu L; Zeng YX; Guan XY
Hum Pathol; 2005 Jul; 36(7):777-83. PubMed ID: 16084947
[TBL] [Abstract][Full Text] [Related]
31. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.
Niki T; Iba S; Tokunou M; Yamada T; Matsuno Y; Hirohashi S
Clin Cancer Res; 2000 Jun; 6(6):2431-9. PubMed ID: 10873096
[TBL] [Abstract][Full Text] [Related]
32. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
33. The number of analyzed lymph nodes - a prognostic factor in colorectal cancer.
Edler D; Ohrling K; Hallström M; Karlberg M; Ragnhammar P
Acta Oncol; 2007; 46(7):975-81. PubMed ID: 17917828
[TBL] [Abstract][Full Text] [Related]
34. [Correlations of chemokine receptor CCR1 expression with metastasis of lymph nodes in colorectal carcinoma tissues].
Ma JA; Qiu ZH; Pei HP
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):714-5. PubMed ID: 19664396
[TBL] [Abstract][Full Text] [Related]
35. [Mapping the sentinel lymph node ex vivo and finding the micrometastasis by CK-immunostaining in carcinoma of the colon and rectum].
Wang FL; Pan ZZ; Wan DS
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):994-7. PubMed ID: 16194357
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer.
Zhang H; Sun XF
Am J Gastroenterol; 2002 Apr; 97(4):1037-41. PubMed ID: 12003384
[TBL] [Abstract][Full Text] [Related]
37. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.
Bernini A; Spencer M; Frizelle S; Madoff RD; Willmott LD; McCormick SR; Niehans GA; Ho SB; Kratzke RA
Cancer Detect Prev; 2000; 24(1):72-9. PubMed ID: 10757125
[TBL] [Abstract][Full Text] [Related]
38. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
[TBL] [Abstract][Full Text] [Related]
39. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
[TBL] [Abstract][Full Text] [Related]
40. The impact of the largest metastasis size on nodal tumor burden in colorectal carcinomas: implications for the sentinel lymph node theory in cancers of the large intestine.
Bori R; Vinh-Hung V; Vajda K; Svébis M; Cserni G
J Surg Oncol; 2007 Jun; 95(8):629-34. PubMed ID: 17492634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
